T2DM promotes colorectal tumor growth through mechanisms such as hyperinsulinemia, which activates the pro-growth PI3K/AKT/mTOR signaling pathway in colonic epithelial cells [79]. This evidence concerns the gene AKT1 and Hyperinsulinemia.